These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 23139925)

  • 1. [Claudins as prognostic factors of breast cancer].
    Szász MA
    Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a claudin-4 and E-cadherin score to predict prognosis in breast cancer.
    Szasz AM; Nemeth Z; Gyorffy B; Micsinai M; Krenacs T; Baranyai Z; Harsanyi L; Kiss A; Schaff Z; Tokes AM; Kulka J
    Cancer Sci; 2011 Dec; 102(12):2248-54. PubMed ID: 21883696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.
    Bouchagier KA; Assimakopoulos SF; Karavias DD; Maroulis I; Tzelepi V; Kalofonos H; Karavias DD; Kardamakis D; Scopa CD; Tsamandas AC
    In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
    Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
    Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R; Kimura N; Harada Y; Ohuchi N
    Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis.
    Szasz AM; Tokes AM; Micsinai M; Krenacs T; Jakab C; Lukacs L; Nemeth Z; Baranyai Z; Dede K; Madaras L; Kulka J
    Clin Exp Metastasis; 2011 Jan; 28(1):55-63. PubMed ID: 20963473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
    Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
    Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of prognostic parameters of E-cadherin status in breast cancer treatment.
    Brzozowska A; Sodolski T; Duma D; Mazurkiewicz T; Mazurkiewicz M
    Ann Agric Environ Med; 2012; 19(3):541-6. PubMed ID: 23020053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
    Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
    Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cadherins as predictive markers of nodal metastasis in breast cancer.
    Madhavan M; Srinivas P; Abraham E; Ahmed I; Mathew A; Vijayalekshmi NR; Balaram P
    Mod Pathol; 2001 May; 14(5):423-7. PubMed ID: 11353052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
    Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.
    Sakamoto K; Imanishi Y; Tomita T; Shimoda M; Kameyama K; Shibata K; Sakai N; Ozawa H; Shigetomi S; Fujii R; Fujii M; Ogawa K
    Ann Surg Oncol; 2012 Feb; 19(2):612-9. PubMed ID: 21913013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
    Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
    Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
    Heimann R; Lan F; McBride R; Hellman S
    Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-catenin expression and claudin expression pattern as prognostic factors of prostatic cancer progression.
    Szász AM; Nyirády P; Majoros A; Szendrõi A; Szûcs M; Székely E; Tõkés AM; Romics I; Kulka J
    BJU Int; 2010 Mar; 105(5):716-22. PubMed ID: 19818082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas.
    Gerhard R; Ricardo S; Albergaria A; Gomes M; Silva AR; Logullo ÂF; Cameselle-Teijeiro JF; Paredes J; Schmitt F
    Breast; 2012 Jun; 21(3):354-60. PubMed ID: 22464177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer.
    Bernardi MA; Logullo AF; Pasini FS; Nonogaki S; Blumke C; Soares FA; Brentani MM
    Oncol Rep; 2012 Jan; 27(1):28-38. PubMed ID: 21956537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis.
    Park D; Kåresen R; Axcrona U; Noren T; Sauer T
    APMIS; 2007 Jan; 115(1):52-65. PubMed ID: 17223851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.